Log in

Seres Therapeutics Earnings Date, Estimates & History

-1.00 (-3.07 %)
(As of 10/20/2020 12:00 AM ET)
Today's Range
Now: $31.60
50-Day Range
MA: $27.83
52-Week Range
Now: $31.60
Volume389,787 shs
Average Volume1.20 million shs
Market Capitalization$2.41 billion
P/E RatioN/A
Dividend YieldN/A


Seres Therapeutics (NASDAQ:MCRB) Earnings Information

Seres Therapeutics last posted its quarterly earnings data on July 28th, 2020. The biotechnology company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.26) by $0.02. The company had revenue of $6.05 million for the quarter, compared to analysts' expectations of $9.67 million. Seres Therapeutics has generated ($1.20) earnings per share over the last year. Seres Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 3rd, 2020 based off prior year's report dates.

Seres Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Seres Therapeutics (NASDAQ:MCRB) Earnings Estimates

2020 EPS Consensus Estimate: ($1.00)
2021 EPS Consensus Estimate: ($2.52)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.24)($0.24)($0.24)
Q2 20201($0.25)($0.25)($0.25)
Q3 20202($0.27)($0.22)($0.25)
Q4 20202($0.27)($0.25)($0.26)
Q1 20213($0.88)($0.28)($0.48)
Q2 20213($1.29)($0.30)($0.63)
Q3 20213($1.49)($0.32)($0.71)
Q4 20213($1.43)($0.33)($0.70)

Seres Therapeutics (NASDAQ MCRB) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
7/28/2020Q2 2020($0.26)($0.28)($0.28)$9.67 million$6.05 millionN/A
5/7/20203/31/2020($0.28)($0.28)($0.28)$8.01 million$8.19 millionListen
3/2/202012/31/2019($0.28)($0.25)($0.25)$6.82 million$7.62 millionTranscript
11/5/2019Q3($0.26)($0.23)($0.23)$6.69 million$7.03 millionTranscript
8/6/2019Q2($0.41)($0.24)($0.24)$10.29 million$12.53 millionN/A
5/2/20193/31/2019($0.43)($0.55)($0.51)$8.61 million$7.32 millionTranscript
3/6/201912/31/2018($0.67)($0.52)($0.52)$3.78 million$10.63 millionTranscript
11/8/2018Q3($0.57)($0.54)($0.54)$23.43 million$9.06 millionN/A
8/2/2018Q2 2018($0.69)($0.68)($0.68)$5.22 million$4.61 millionN/A
5/9/2018Q1 2018($0.75)($0.69)($0.69)$3.00 million$3.97 millionN/A
3/8/2018Q4 2017($0.73)($0.71)($0.71)$3.00 million$3.06 millionTranscript
11/8/2017Q3 2017($0.39)($0.17)($0.17)$17.29 million$23.00 millionN/A
8/3/2017Q2 2017($0.59)($0.69)($0.69)$3.00 million$3.00 millionListen
5/4/2017Q1 2017($0.65)($0.63)($0.63)$3.00 million$3.02 millionListen
3/16/2017Q4 2016($0.70)($0.6260)($0.63)$3.00 million$3.00 millionN/A
11/10/2016Q316($0.55)($0.46)($0.46)$10.38 million$13.02 millionListen
8/11/2016Q216($0.46)($0.70)($0.70)$4.20 million$3.00 millionListen
5/16/2016Q116($0.48)($0.50)($0.50)$1.25 million$2.71 millionListen
2/25/2016Q4 2015($0.40)($0.41)($0.41)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 10/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.